Cargando…

SMK-1/PPH-4.1–mediated silencing of the CHK-1 response to DNA damage in early C. elegans embryos

Mostrar otras versiones (2)

Detalles Bibliográficos
Autores principales:	Kim, Seung-Hwan, Holway, Antonia H., Wolff, Suzanne, Dillin, Andrew, Michael, W. Matthew
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2009
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654128/ http://dx.doi.org/10.1083/jcb.20070518220090127c

Ejemplares similares

SMK-1/PPH-4.1–mediated silencing of the CHK-1 response to DNA damage in early C. elegans embryos
por: Kim, Seung-Hwan, et al.
Publicado: (2007)

SMK-1/PPH-4.1–mediated silencing of the CHK-1 response to DNA damage in early C. elegans embryos
por: Kim, Seung-Hwan, et al.
Publicado: (2010)

Checkpoint silencing during the DNA damage response in Caenorhabditis elegans embryos
por: Holway, Antonia H., et al.
Publicado: (2007)

Checkpoint silencing during the DNA damage response in Caenorhabditis elegans embryos
por: Holway, Antonia H., et al.
Publicado: (2006)

DAF-16 and SMK-1 Contribute to Innate Immunity During Adulthood in Caenorhabditis elegans
por: McHugh, Daniel R., et al.
Publicado: (2020)

Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation
por: Yu, Xinfang, et al.
Publicado: (2020)

Chk1, Chk2, is the amplifier on?
por: Dove, Alan W.
Publicado: (2001)

Autophosphorylation of the Smk1 MAPK is spatially and temporally regulated by Ssp2 during meiotic development in yeast
por: Tio, Chong Wai, et al.
Publicado: (2015)

CHK1 monitors spindle assembly checkpoint and DNA damage repair during the first cleavage of mouse early embryos
por: Ju, Jia‐Qian, et al.
Publicado: (2020)

The Rad53(CHK1/CHK2)-Spt21(NPAT) and Tel1(ATM) axes couple glucose tolerance to histone dosage and subtelomeric silencing
por: Bruhn, Christopher, et al.
Publicado: (2020)

Regulation of Chk1
por: Tapia-Alveal, Claudia, et al.
Publicado: (2009)

The meiosis-specific Cdc20 family-member Ama1 promotes binding of the Ssp2 activator to the Smk1 MAP kinase
por: Omerza, Gregory, et al.
Publicado: (2018)

SMK-17, a MEK1/2-specific inhibitor, selectively induces apoptosis in β-catenin-mutated tumors
por: Kiga, Masaki, et al.
Publicado: (2015)

The Smk1 MAPK and Its Activator, Ssp2, Are Required for Late Prospore Membrane Development in Sporulating Saccharomyces cerevisiae
por: Durant, Matthew, et al.
Publicado: (2021)

Isc10, an inhibitor of the Smk1 MAPK, prevents activation loop autophosphorylation and substrate phosphorylation through separate mechanisms
por: Rimal, Abhimannyu, et al.
Publicado: (2022)

Postpartum haemorrhage (PPH) rates in randomized trials of PPH prophylactic interventions and the effect of underlying participant PPH risk: a meta-analysis
por: Hawker, Lydia, et al.
Publicado: (2020)

Tumour growth environment modulates Chk1 signalling pathways and Chk1 inhibitor sensitivity
por: Massey, Andrew J.
Publicado: (2016)

KA1-targeted regulatory domain mutations activate Chk1 in the absence of DNA damage
por: Gong, Eun-Yeung, et al.
Publicado: (2015)

Regulated Degradation of Chk1 by chaperone-mediated autophagy in response to DNA damage
por: Park, Caroline, et al.
Publicado: (2015)

Clinical and functional significance of CHK1-S, an alternatively spliced isoform of the CHK1 gene, in hepatocellular carcinoma
por: Hu, Guanghui, et al.
Publicado: (2020)

Pt(PPh(3))(4) and Pt(PPh(3))(4)@IL catalyzed hydroboration of ketones
por: Krupa, Barbara, et al.
Publicado: (2023)

BRD7 suppresses tumor chemosensitivity to CHK1 inhibitors by inhibiting USP1-mediated deubiquitination of CHK1
por: Li, Lemin, et al.
Publicado: (2023)

Aerobic dichlorvos degradation by Pseudomonas stutzeri smk: complete pathway and implications for toxicity in Mus musculus
por: Parte, Satish G., et al.
Publicado: (2020)

ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1
por: Zhang, Peijing, et al.
Publicado: (2014)

APE1 assembles biomolecular condensates to promote the ATR–Chk1 DNA damage response in nucleolus
por: Li, Jia, et al.
Publicado: (2022)

Chk1 suppressed cell death
por: Meuth, Mark
Publicado: (2010)

Checkmate to CHK1 in T-cell ALL?
por: Sarmento, Leonor M., et al.
Publicado: (2015)

Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells
por: Ando, Kiyohiro, et al.
Publicado: (2019)

Structural basis for recruitment of the CHK1 DNA damage kinase by the CLASPIN scaffold protein
por: Day, Matthew, et al.
Publicado: (2021)

Keeping RelApse in Chk: molecular mechanisms of Chk1 inhibitor resistance in lymphoma
por: Black, Elizabeth M., et al.
Publicado: (2022)

A Mitochondrial Transcription Termination Factor, ZmSmk3, Is Required for nad1 Intron4 and nad4 Intron1 Splicing and Kernel Development in Maize
por: Pan, Zhenyuan, et al.
Publicado: (2019)

Negative regulation of G2-M by ATR (mei-41)/Chk1(Grapes) facilitates tracheoblast growth and tracheal hypertrophy in Drosophila
por: Kizhedathu, Amrutha, et al.
Publicado: (2018)

Characterization and Transcriptome Analysis of Maize Small-Kernel Mutant smk7a in Different Development Stages
por: Wang, Jing, et al.
Publicado: (2023)

CCAR2/DBC1 is required for Chk2-dependent KAP1 phosphorylation and repair of DNA damage
por: Magni, Martina, et al.
Publicado: (2015)

Cyclin D1 Binding Protein 1 Responds to DNA Damage through the ATM–CHK2 Pathway
por: Niwa, Yusuke, et al.
Publicado: (2022)

Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer
por: Liu, Kang, et al.
Publicado: (2021)

Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation via derepression of Chk1 catalytic activity
por: Walker, M, et al.
Publicado: (2009)

A novel Chk1-binding peptide that enhances genotoxic sensitivity through the cellular redistribution of nuclear Chk1
por: Kim, Kwang Seok, et al.
Publicado: (2016)

Dominant mutations in CHK1 cause pronuclear fusion failure and zygote arrest that can be rescued by CHK1 inhibitor
por: Zhang, Honghui, et al.
Publicado: (2021)

Trial Watch: Targeting ATM–CHK2 and ATR–CHK1 pathways for anticancer therapy
por: Manic, Gwenola, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cbnmscd3muddr12jv3j1rfja95